Top compounds associated with response to OR4C13


Feature Type Standardized
Nominal ANOVA
mRNA TPCA-1 GDSC1000 pan-cancer AAC 0.029 0.3
mRNA Sunitinib CTRPv2 pan-cancer AAC -0.034 0.3
mRNA myricetin CTRPv2 pan-cancer AAC -0.038 0.3
mRNA ciclopirox CTRPv2 pan-cancer AAC -0.032 0.3
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.3
mRNA BRD9876 CTRPv2 pan-cancer AAC -0.038 0.3
mRNA LY-2183240 CTRPv2 pan-cancer AAC -0.031 0.3
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.3
mRNA MLN2238 CTRPv2 pan-cancer AAC 0.033 0.3
mRNA KU-0063794 CTRPv2 pan-cancer AAC -0.034 0.3
Download CSV